Ptosis during hematologic malignancy in children.

Area of Science:

• Neurology
• Hematology
• Oncology

Background:

• Hematologic malignancies can present with neurological complications.
• Chemotherapy and central nervous system (CNS) involvement are potential causes of neurological symptoms.
• Distinguishing between these causes based on clinical presentation and imaging is often difficult.

Observation:

• Ptosis, a drooping eyelid, is a specific neurological symptom observed in patients.
• Three cases of hematologic malignancy with ptosis are presented.
• Worsening neurological symptoms may indicate CNS involvement.

Findings:

• Clinical and neuroimaging features of three patients with ptosis secondary to hematologic malignancy are detailed.
• The study highlights the diagnostic challenges in differentiating chemotherapy-induced vs. CNS-related ptosis.
• Increased neurological symptom severity serves as a critical warning sign for CNS involvement.

Implications:

• This study aids in understanding the differential diagnosis of ptosis in hematologic malignancy patients.
• Improved recognition of CNS involvement can lead to timely and appropriate treatment adjustments.
• Neuroimaging and clinical monitoring are crucial for managing neurological complications in hematologic cancers.